Aurinia Pharmaceuticals (AUPH) Q2 Earnings Miss Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.88%. A quarter ago, it was expected that this biotechnology company would post earnings of $0.08 per share when it actually produced earnings of $0.16, delivering a surprise of +100%.Over the last four q ...